12th EACS

EU_EACS_Static_Bannerv2

Please Click Here to See Important Information Regarding the Pending Application with The European Union of Medical Specialists (UEMS)

About the Program

Program Overview
Target Audience
Learning Objectives
Course Director
Faculty
Accreditation Statement
Credit Designation
Disclosure of Conflicts of Interest
Instructions for Participation and Credit
Request for Program Slides and Review

Program Overview

Two programs, an EACS Web Symposium and an EACS Newsletter, will review and discuss the key studies on antiretroviral therapy presented at the 12th European AIDS Conference*. Both programs feature presentations and commentary from Jurgen Rockstroh MD, Calvin Cohen MD, Jose Arribas MD and Graeme Moyle, MD.

Each program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine and is intended for health care providers who treat HIV-positive patients, there are no prerequisites.

Program Note: An application has been submitted to the European Union of Medical Specialists (UEMS) for approval to provide direct EACCME accredited continuing medical education for European participants and is pending. Currently, participating non-US physicians can receive the specified number of AMA PRA Category 1 Credits specific to the program and have these converted to their national CME credit in their specific country, where applicable. Similarly, non-US health care providers other than physicians can receive a certificate of completion and use this to acquire national credit through their national continuing medical education board/association, where applicable. If you have any questions, please contact ViralEd at admin@viraled.com

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.

Back to Top

Target Audience

These activities have been designed to meet the educational need of physicians involved in the care of patients with HIV infection.

Learning Objectives

Explain the key new studies on ARV therapy presented at the 12th EACS.
Outline how to use the advances in clinical management of HIV-positive patients presented and discussed at the 12th EACS to improve patient care.
Describe how to apply data presented and discussed at the 12th EACS regarding the treatment of ARV-naive and experienced patients.
Analyze treatment options and construct appropriate ARV regimens.

Release Date: November 23, 2009
Expiration Date: November 23, 2010

Estimated time to complete the EACS Web Symposium: 1 hour 30 minutes

Course Director and Moderator

Jurgen Rockstroh, MD
Co-Chairman,12th European AIDS Conference
Professor, University of Bonn
Bonn, Germany

Faculty

Jose Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain

Calvin J. Cohen, MD, MS
Research Director, CRI New England,
Clinical Instructor, Harvard Medical School
Boston, Massachusetts

Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, UK

Accreditation Statement

These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designates this EACS Web Symposium for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Postgraduate Institute for Medicine designates this EACS Newsletter for a maximum of .75 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of these activities to disclose any real or apparent conflict of interest they may have as related to the content of CME activites. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in these activities, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:

Dr. Jurgen Rockstroh:

Consulting Fees: Abbott; Bristol-Myers Squibb; BI; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead; Schering
Speakers' Bureau: Abbott; Bristol-Myers Squibb; BI; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead

Dr. Graeme Moyle:

Contracted Research: Bristol-Myers Squibb; Merck & Co.; GlaxoSmithKline; Gilead; Thera Technologies; Aread Biosciences; Pfizer
Consulting Fees: Bristol-Myers Squibb; Merck & Co.; GlaxoSmithKline; Gilead; Thera Technologies; Aread Biosciences; Tibotec
Speakers' Bureau: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck & Co.; Tibotec

Dr. Calvin Cohen:

Contracted Research: Bristol-Myers Squibb; Gilead; Merck & Co.; Pfizer; Tibotec
Consulting Fees: Bristol-Myers Squibb; Gilead; Merck & Co.; Pfizer; Tibotec
Speakers' Bureau: Bristol-Myers Squibb; Gilead; Merck & Co.; Tibotec

Dr. Jose Arribas:

Consulting Fees: Merck & Co.; Abbott; Tibotec; Janssen; Gilead; GlaxoSmithKline; Pfizer; Biogen; Avexa; Bristol-Myers Squibb

The planners and managers reported the following financial relationships or relationships to products or devices they or thier spouse/life partner have with commercial interests related to the content of these CME activities:

The following PIM planners and managers: Linda Graham, RN, BSN, BA, Jan Hixon, RN, BSN, MS, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD and Jan Schultz, RN, MSN, CCMEP and ViralEd, LLC planners and managers: Brian Boyle, MD, JD, Rick Gordon, Tracey Barrett, RN and Mathew Banks hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of these activities of any amount during the past 12 months.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for these activities. During the period, November 23, 2009 through November 23, 2010, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

To take the post-test for the EACS Web Symposium click here: EACS Web Symposium

To take the post-test for the EACS Newsletter, click here: EACS Newsletter

Request for Program Slides and Review

To request a copy of the EACS Web Symposium program slides as well as further education on how to use the slides please Click Here to fill out a content request form.

Back to Top

PIM-4C-logo_sml

Supported by an educational grant from Merck & Co., Inc.

Share this page: